On April 21, 2026, TNH Hospital Group officially announced a significant shift in its senior leadership. This transition is framed... Read more
Category: Uncategorized
Ownership Restructuring: DHG’s Challenges in Sustaining Public Company Status
During the Annual General Meeting held on April 21, 2026, DHG Pharma (Stock Code: DHG) addressed legal hurdles regarding its... Read more
Elevating Testing Standards: Regulatory Reforms to Ensure National Pharmaceutical Security
On the afternoon of April 21, 2026, the Ministry of Health held a pivotal meeting to discuss amendments to Circular... Read more
Administrative Enforcement: 37 Cosmetic Products Recalled Due to Regulatory Non-Compliance
On April 21, 2026, the Drug Administration of Vietnam issued a formal sanction against a Hanoi-based distributor following a regulatory... Read more
Cosmetic company in HCMC fined for using banned substance Dexamethasone
The Ho Chi Minh City Department of Health has recently announced administrative sanctions against several entities in the pharmaceutical and... Read more
Navigating the Shift to Fractional Leadership: 5 Strategic Questions for Senior Executives
Amidst AI-driven restructuring and market volatility, "Fractional Work" has emerged as a resilient alternative for senior leaders. By holding part-time... Read more
Redefining Resistance: From Obstacle to Strategic Data in Change Management
In organizational governance, negative reactions from staff when facing transitions are often labeled as "reflexive resistance." However, through the lens... Read more
Eli Lilly enters $7 billion agreement to acquire Kelonia Therapeutics
Eli Lilly has entered into a definitive agreement to acquire Kelonia Therapeutics for potential consideration of up to $7 billion.... Read more
Pfizer at a Crossroads: Leadership, Strategy, and Narrative Risks
Pfizer is currently at a critical inflection point following its pandemic-era surge. Despite its massive scale and scientific foundation, the... Read more








